Hogar y Estilo de Vida
5 hábitos para añadir años a tu vida
Ver más
Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 11.003.089 | Circulating Tumor Dna And Circulating Tumor Cells For Cancer Management (Liquid Biopsy) | Sep 20, 2024 | Sep 20, 2025 | Circulating tumor dna (ctdna) and circulating tumor cells (ctcs) in peripheral blood, referred to as... | Ver |
| 11.003.090 | Gene Expression Profiling For Uveal Melanoma | Mar 12, 2025 | Mar 20, 2026 | Uveal melanoma is associated with a high rate of metastatic disease, and survival after the development of... | Ver |
| 11.003.092 | Proteogenomic Testing For Patients With Cancer | Jul 08, 2024 | Jul 20, 2025 | Proteogenomics refers to the integration of genomic information with proteomic and transcriptomic information... | Ver |
| 11.003.093 | Genetic Testing For Mitochondrial Disorders | Oct 08, 2024 | Oct 20, 2025 | Mitochondrial diseases are multisystem diseases that arise from dysfunction in the mitochondrial protein... | Ver |
| 11.003.094 | Serum Biomarket Panel Testing For Systemic Lupus Erythematosus And Other Connective Tissue Deseases | Jul 08, 2024 | Jul 20, 2025 | Systemic lupus erythematosus (sle) is an autoimmune connective tissue disease (ctd) that can be difficult to... | Ver |
| 11.003.095 | Genotype-Guided Tamoxifen Treatment | Sep 13, 2024 | Sep 20, 2025 | Tamoxifen is prescribed as a component of adjuvant endocrine therapy to prevent endocrine receptor-positive... | Ver |
| 11.003.096 | Miscellaneous Genetic And Molecular Diagnostic Tests | Aug 12, 2024 | Aug 20, 2025 | There are numerous commercially available genetic and molecular diagnostic, prognostic, and therapeutic tests... | Ver |
| 11.003.097 | Gene Expression Profiling For Cutaneous Melanoma | Jun 07, 2024 | Jun 20, 2025 | Laboratory tests have been developed that detect the expression of different genes in pigmented lesions or... | Ver |
| 11.003.098 | Use Of Common Genetic Variants (Single Nucleotide Variants) To Predict Risk Of Nonfamilial Breast Cancer | Nov 15, 2024 | Nov 20, 2025 | Several single nucleotide variants (snvs), which are single base-pair variations in the dna sequence of the... | Ver |
| 11.003.099 | Circulating Tumor Dna For Management Of Non-Small-Cell Lung Cancer (Liquid Biopsy) | Dec 10, 2021 | Policy Archived | ... | Ver |
| 11.003.100 | Dna-Based Testing For Adolescent Idiopathic Scoliosis | Mar 05, 2021 | Policy Archived | Adolescent idiopathic scoliosis (ais) is a disease of unknown etiology that causes mild-to-severe spinal... | Ver |
| 11.003.101 | Genetic Testing For Alpha 1 – Antitrypsin Deficiency | Feb 19, 2025 | Feb 20, 2026 | Alpha1-antitrypsin deficiency (aatd) is an autosomal recessive genetic disorder that results in decreased... | Ver |
| 11.003.102 | Genetic Testing For Neurofibromatosis | Feb 05, 2025 | Feb 20, 2026 | Neurofibromatoses are autosomal dominant genetic disorders associated with tumors of the peripheral and... | Ver |
| 11.003.103 | Gene Therapy For Inherited Retinal Dystrophy | Feb 19, 2025 | Feb 20, 2026 | Inherited retinal dystrophy can be caused by recessive variants in the rpe65 gene. patients with biallelic... | Ver |
| 11.003.104 | Genetic Testing For Lipoprotein(A) Variant(S) As A Decision Aid For Aspirin Treatment | Dec 28, 2021 | Policy Archived | Lipoprotein(a) (lpa) is a lipid-rich particle similar to low-density lipoprotein and has been determined to... | Ver |
| 11.003.105 | Microarray-Based Gene Expression Profile Testing For Multiple Myeloma Risk Stratification | Dec 05, 2024 | Nov 20, 2025 | Summary multiple myeloma is a genetically complex-and invariably fatal-disease. a host of well-characterized... | Ver |
| 11.003.106 | Genetic Testing For Heterozygous Familial Hypercholesterolemia | Nov 12, 2024 | Nov 20, 2025 | Complete appendix to guidelines available at http://journals.aace.com. endocr pract. apr 02 2017; 23(4):... | Ver |
| 11.003.107 | Genetic Testing For Hereditary Pancreatic Cancer | Mar 03, 2025 | Mar 20, 2026 | Pancreatic cancer is the fourth leading cause of cancer death in the united states, accounting for 8.3% of... | Ver |
| 11.003.108 | Measurement Of Serum Antibodies To Selected Biologic Agent | Dec 20, 2024 | Dec 20, 2025 | Biologic agents used to treat autoimmune diseases include infliximab, adalimumab, vedolizumab, and... | Ver |
| 11.003.109 | Human Leukocyte Antigen Testing For Celiac Disease | Dec 09, 2024 | Dec 20, 2025 | Celiac disease (cd) is currently diagnosed by serology, medical history, and response to a gluten-free diet,... | Ver |
